Modern attempts at drug treatment of fetal growth retardation in different terms of pregnancy

Abstract

Diagnosis, treatment, and prevention of fetal growth retardation (FGR) is one of the urgent problems of modern obstetrics [1–6]. According to various authors [4,5], the prevalence of this syndrome in various obstetric pathologies ranges from 11% to 36%. In recent years, the incidence of FGR syndrome has been increasing. This is due to both the improvement of antenatal diagnosis and the instability of socio-economic conditions in modern society.